Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Out of Specification (OOS) Handling in Creams Production

Posted on By

SOP for Out of Specification (OOS) Handling in Creams Production

Standard Operating Procedure for Handling Out of Specification (OOS) Results in Creams Production

1) Purpose

The purpose of this SOP is to establish a standardized process for handling Out of Specification (OOS) results in creams production, ensuring timely identification, investigation, and resolution of OOS results to maintain product quality and compliance with regulatory requirements.

2) Scope

This SOP applies to all personnel involved in the production and quality control of creams. It covers the handling of OOS results obtained during raw material testing, in-process testing, and final product testing.

3) Responsibilities

The Quality Assurance (QA) Manager is responsible for overseeing the OOS handling process. Quality Control (QC) personnel are responsible for identifying and reporting OOS results. Production personnel are responsible for assisting in the investigation and implementation of corrective actions.

See also  SOP for Change Management in Creams Production

4) Procedure

4.1 Identification and Reporting of OOS Results

4.1.1 Identify any result that falls outside the established specification limits during testing.

4.1.2 Immediately notify the QA Manager and document the OOS result in the laboratory notebook or appropriate record.

4.1.3 Initiate an OOS Report, including the following information:

  • Test performed
  • Specification limits
  • Obtained result
  • Date and time of the test
  • Analyst’s name

4.2 Preliminary Investigation

4.2.1 Conduct a preliminary investigation to determine if the OOS result is due

to a laboratory error.

4.2.2 Review the analytical method, equipment calibration, reagent validity, and analyst’s technique.

4.2.3 If a laboratory error is identified, document the findings and perform a retest.

4.2.4 If no laboratory error is identified, proceed to a full-scale OOS investigation.

4.3 Full-Scale OOS Investigation

4.3.1 Form an investigation team including QA, QC, and Production representatives.

4.3.2 Review all relevant data, including batch records, raw material certificates, and in-process control results.

See also  SOP for Inventory Control in Creams Production

4.3.3 Perform additional testing if necessary to confirm the OOS result.

4.3.4 Use root cause analysis tools (e.g., 5 Whys, Fishbone Diagram) to identify the root cause of the OOS result.

4.3.5 Document all findings in the OOS Report.

4.4 Corrective and Preventive Actions (CAPA)

4.4.1 Develop corrective actions to address the root cause of the OOS result.

4.4.2 Develop preventive actions to prevent recurrence of the OOS result.

4.4.3 Assign responsibilities and timelines for implementing CAPA.

4.4.4 Document all CAPA activities in the OOS Report.

4.5 Review and Approval

4.5.1 Review the completed OOS Report and CAPA plan with the QA Manager and other relevant departments.

4.5.2 Obtain approval for the OOS Report and CAPA plan from QA and other relevant stakeholders.

4.6 Implementation and Follow-Up

4.6.1 Implement the approved corrective and preventive actions according to the assigned timelines.

See also  SOP for Process Optimization for Creams

4.6.2 Monitor the effectiveness of CAPA to ensure the OOS result does not recur.

4.6.3 Conduct follow-up reviews to confirm the successful implementation of CAPA.

4.7 Documentation and Records

4.7.1 Maintain all records related to OOS handling, including OOS Reports, investigation findings, and CAPA documentation.

4.7.2 Ensure that all OOS records are retained according to the company’s document retention policy.

5) Abbreviations, if any

OOS: Out of Specification

QA: Quality Assurance

QC: Quality Control

CAPA: Corrective and Preventive Actions

SOP: Standard Operating Procedure

6) Documents, if any

OOS Report Form

Root Cause Analysis Tools (e.g., 5 Whys, Fishbone Diagram)

CAPA Records

7) Reference, if any

ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

FDA Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production

8) SOP Version

Version 1.0

Creams Tags:Analytical method development for creams, Calibration of cream equipment, Cleaning equipment for creams, Cream homogenization SOP, Cream preparation SOP, Documentation for cream production, Emulsification in creams, Final product inspection for creams, Formulation development for creams, In-process testing for creams, Labeling SOP for creams, Maintaining sterility in creams, Microbial testing in creams, Oil-in-water cream formulation, Packaging SOP for creams, Particle size analysis in creams, pH testing of creams, Pharmaceutical cream manufacturing, Preventing contamination in creams, Process optimization for creams, Process validation for creams, Quality control of creams, Raw material inspection for creams, Rheological testing for creams, Stability testing of creams, Storage conditions for creams, Training SOP for cream production, Viscosity testing for creams, Waste disposal in cream production, Water-in-oil cream process

Post navigation

Previous Post: SOP for Deviation Handling in Creams Production
Next Post: SOP for Root Cause Analysis in Creams Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version